Jacob Gasienica

Apr 6, 2024 | annalsofvascularsurgery.com | Richard Li |Jacob Gasienica |Anders Gould |Brian Wheatley

Abstract The use of cryopreserved saphenous veins (CSVs) for the treatment of lower extremity peripheral arterial disease is an attractive option when there is no available autogenous vein. Prior studies found CSVs are at risk for aneurysmal degeneration requiring reoperation.